BiotechTube

Fidaxomicin + Vancomycin + Placebo

ApprovedTerminated
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Clostridium Difficile

Conditions

Clostridium Difficile

Trial Timeline

Nov 29, 2012 → Apr 15, 2013

NCT ID
NCT01775397

About Fidaxomicin + Vancomycin + Placebo

Fidaxomicin + Vancomycin + Placebo is a approved stage product being developed by Astellas Pharma for Clostridium Difficile. The current trial status is terminated. This product is registered under clinical trial identifier NCT01775397. Target conditions include Clostridium Difficile.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01775397ApprovedTerminated

Competing Products

20 competing products in Clostridium Difficile

See all competitors
ProductCompanyStageHype Score
Fidaxomicin + Treatment for CDI other than fidaxomicin TypeAstellas PharmaPre-clinical
23
OPT-80 + vancomycinAstellas PharmaPhase 3
77
Fidaxomicin oral suspension + Fidaxomicin tablets + Vancomycin oral liquid + Vancomycin capsulesAstellas PharmaPhase 3
77
Fidaxomicin + VancomycinAstellas PharmaApproved
85
Fidaxomicin + VancomycinMerckApproved
85
fidaxomicin + PlaceboMerckPhase 3
77
Surotomycin + PlaceboMerckPhase 1
33
CB-183,315 + Placebo + VancomycinMerckPhase 2
52
Surotomycin + PlaceboMerckPhase 1
33
MK-6072 + MK-3415A + Placebo + SOCMerckPhase 3
77
Vancomycin + FidaxomicinMerckApproved
85
FidaxomicinMerckPre-clinical
23
Bezlotoxumab + Standard CDI treatmentMerckPre-clinical
23
MK-3415 + MK-6072 + MK-3415A + Placebo + SOCMerckPhase 3
77
Fidaxomicin + Vancomycin + Matching Placebo to FidaxomicinMerckPhase 3
77
bezlotoxumab + Vancomycin OralMerckApproved
85
Bezlotoxumab + Placebo + Antibacterial drug treatment (ABD)MerckPhase 3
77
Bezlotoxumab Injection [Zinplava]MerckPre-clinical
23
PAR-101/OPT-80 + VancomycinMerckPhase 3
77
fidaxomicinMerckPhase 2
52

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85